Comments
Nitta Gelatin India, expects its Gelixer CollagenPep pill that relieves joint and knee pain to be its growth driver. The company is a joint-venture between Kerala State Industrial Corporation and Nitta Gelatin of Japan.
Addressing a press conference on the launch of Gelixer CollagenPep, Mr G. Suseelan, Managing Director, NGL, said that the gelatine derivative is expected to bring revenues to the tune of Rs 50 crore in the next three years.
Bombay Stock Exchange-listed NGL reported a net profit of Rs 25 crore on a turnover of Rs 200 crore last year.
Priced at Rs 300 for 150 grams, Gelixer CollagenPep is its first over-the-counter product. It was launched in Kerala last June. So far, the company has been producing and supplying raw materials and intermediate products to the manufacturers.
Gelixer CollagenPep, made of gelatine obtained from cattle bones, acts as a functional food supplement for knee pain and osteoarthritis and promotes joint flexibility, Mr Suseelan said. NGL is in the process of setting up a plant in Gujarat at an investment of Rs 30 crore. The company has one plant each in Kerala and Maharashtra.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.